Numerical Aberrations of Chromosome 8 in Gastric Cancer Detected by Fluorescence In Situ Hybridization

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 155-159

  Panani, Anna D ^a   Ferti, Angeliki D ^a   Avgerinos, Alexandros ^a   Raptis, Satirios A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Chromosome 8 aberrations; Fluorescence in situ hybridization; Gastric cancer; Interphase cytogenetics

Indexed keywords

SATELLITE DNA;

ADVANCED CANCER; ARTICLE; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME NUMBER; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOGENETICS; DNA PROBE; EVALUATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MONOSOMY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; STOMACH CARCINOGENESIS; TECHNIQUE; TETRASOMY; TRISOMY;

ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; STOMACH NEOPLASMS;

EID: 1442350540     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Luk GD: Tumors of the stomach In: Gastrointestinal and Liver Disease. Pathophysiology, Diagnosis, Management. 6th ed (Feldman M, Scharschmidt BF, Sleisenger MH eds). Philadelphia, WB Saunders, 1998, pp: 733-757.
2. Ochi H, Takeuchi J, Douglass H and Sandberg AA: Trisomy X as a possible initial chromosome change in a gastric cancer. Cancer Genet Cytogenet 12: 57-61, 1984.
3. Ferti-Passantonopoulou AD, Panani AD, Vlachos JD and Raptis SA: Common cytogenetic findings in gastric cancer. Cancer Genet Cytogenet 24: 63-73, 1987.
4. Xiao S, Geng JS, Feng XL, Liu QZ and Li P: Cytogenetic studies of eight primary gastric cancers. Cancer Genet Cytogenet 58: 79-84, 1992.
5. Panani AD, Ferti A, Malliaros S and Raptis S: Gastric cancer with an i(8q) and long survival. Cancer Genet Cytogenet 58: 214-215, 1992.
6. Seruca R, Castedo S, Correia C, Gomes P, Carneiro F, Soares P, De Jong B and Sobrinho-Simoes M: Cytogenetic findings in eleven gastric carcinomas. Cancer Genet Cytogenet 68: 42-48, 1993.
7. Panani AD, Ferti A, Malliaros S and Raptis S: Cytogenetic study of 11 gastric adenocarcinomas. Cancer Genet Cytogenet 81: 169-172, 1995.
8. Stamouli MI, Ferti AD, Panani AD, Raftakis J, Consoli C, Raptis SA and Young BD: Application of multiplex fluorescence in situ hybridization in the cytogenetic analysis of primary gastric carcinoma. Cancer Genet Cytogenet 135: 23-27, 2002.
9. Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M, Nording S, Haapiainen R, Kivilaakso E and Knuutila S: 17q 12-21 amplification, a novel recurrent genetic change in intestinal type of gastric carcinoma. Genes Chromosomes Cancer 20: 38-43, 1997.
10. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takayashi T, Nakamura Y, Abe T and Inazawa J: Gains, losses and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 24: 299-305, 1999.
11. Wu MS, Chang MC, Huang SP, Tseng CC, Sheu JC, Lin YM, Shun CT, Lin MT and Lin JT: Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer 30: 80-86, 2001.
12. Koo SH, Kwon KC, Shin SY, Jeon YM, Park JW, Kim SH and Noh SM: Genetic alterations of gastric cancer: Comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet 117: 97-103, 2000.
13. Wu CW, Chen GD, Faun CSJ, Lee AFY, Chi CW, Liu JM, Weier U and Chen JY: Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer 35: 219-231, 2002.
14. Dekken HV, Pizzolo JG, Kelsen DP and Melaled MR: Targeted cytogenetic analysis of gastric tumors by in situ hybridization with a set of chromosome-specific DNA probes. Cancer 66: 491-497, 1990.
15. Han K, Oh EJ, Kim SY, Kim YG, Lee YK, Kang CS, Kim BK, Kim WL, Shim SI and Kim SM: Chromosomal numerical aberrations in gastric carcinoma: analysis of 18 cases using in situ hybridization. Cancer Genet Cytogenet 92: 122-129, 1996.
16. Beuzen F, Dubois S and Flejou JF: Chromosomal numerical aberrations are frequent in gastric and esophageal adenocarcinomas. a study using in situ hybridization. Histopathology 37: 241-249, 2000.
17. Fringes B, Mayhew TM, Reith A, Gates J and Ward DC: Numerical aberrations of chromosomes 1 and 17 correlate with tumor site in human gastric carcinoma. Laboratory Investigation 80: 1501-1508, 2000.
18. Stocks SC, Pratt N, Sales M, Johnston DA, Thompson AM, Carey FA and Kernohan NM: Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization detected abnormalities segregate with junctional adenocarcinomas. Genes Chromosome Cancer 32: 50-58, 2001.
19. Oota K and Sobin LH: Histological typing of gastric and esophageal tumors. In: International Histological Classification of Tumors. No 18, WHO, Genova, 1997.
20. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histological classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
21. Hopman AHN, Ramaekers FCS, Raap AK, Beck JLM, Devilee P, Ploeg M and Vooijs GP: In situ hybridization as a tool to study numerical aberrations in solid bladder tumors. Histochemistry 89: 307-316, 1988.
22. Castedo S, Correia C, David L and Sobrinbo-Simoes M: Isochromosome 8q. A recurrent change in gastric carcinoma. Cancer Genet Cytogenet 54: 137-38, 1991.
23. Baffa R, Santoro R, Bullrich F, Mandes B, Ishii H and Eroce CM: Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer. Clin Cancer Res 6: 1372-77, 2000.
24. Watson PH, Safneck JR, Le K, Dubik D and Shiu RP: Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902-907, 1993.
25. Suzuki S, Tenjin T, Watanabe H, Matsushima S, Shibuya T and Tanaka S: Low level c-myc gene amplification in gastric cancer detected by dual-color fluorescence in situ hybridization analysis. J Surg Oncol 66: 173-178, 1997.
26. Kozma L, Kiss I, Hajdu J, Szentkereszty Z, Szakall S and Ember I: C-myc amplification and cluster analysis in human gastric carcinoma. Anticancer Res 21: 707-710, 2001.
27. Takahashi Y, Shintaku K, Ishii Y, Asai S, Ishikawa K and Fujii M: Analysis of MYC and chromosome 8 copy number changes in gastrointestinal cancer by dual-color fluorescence in situ hybridization. Cancer Genet Cytogenet 107: 61-64, 1998.
28. Nakata B, Onoda N, Chung YS et al: Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein. Gan To Kayaku Ryoho 22: 176-179, 1995.
29. Wada Y, Igawa M, Shiina H, Shigeno K, Yokogi H, Urakami S, Yoneda I and Maruyma R: Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma. Br J Cancer 7: 2003-2007, 1998.
30. Tsukamoto F, Miyoshi Y, Egawa C, Kasugai T, Inazawa J and Nogushi S: Clinopathologic study of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization. Cancer 93: 165-170, 2001.